Circulating biologically active oxidized phospholipids show on-going and increased oxidative stress in older male mice

[1]  T. McIntyre.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation. , 2012, Biochimica et biophysica acta.

[2]  Renliang Zhang,et al.  Oxidatively Truncated Phospholipids Are Required Agents of Tumor Necrosis Factor α (TNFα)-induced Apoptosis* , 2012, The Journal of Biological Chemistry.

[3]  J. Major,et al.  Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. , 2011, Blood.

[4]  T. McIntyre,et al.  Human TMEM30a Promotes Uptake of Antitumor and Bioactive Choline Phospholipids into Mammalian Cells , 2011, The Journal of Immunology.

[5]  S. Reddy,et al.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. , 2010, The Journal of clinical investigation.

[6]  Renliang Zhang,et al.  Chronic Alcohol Exposure Increases Circulating Bioactive Oxidized Phospholipids* , 2010, The Journal of Biological Chemistry.

[7]  A. Feldstein,et al.  Suppression of Mitochondrial Function by Oxidatively Truncated Phospholipids Is Reversible, Aided by Bid, and Suppressed by Bcl-XL* , 2009, The Journal of Biological Chemistry.

[8]  D. Stafforini,et al.  The emerging roles of PAF acetylhydrolase This work was supported by National Institutes of Health Grants HL44513, HL35828, and HL087018. Published, JLR Papers in Press, October 6, 2008. , 2009, Journal of Lipid Research.

[9]  X. Chen,et al.  Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[10]  D. Stafforini.  Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2) , 2009, Cardiovascular Drugs and Therapy.

[11]  Frits Mastik,et al.  Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.

[12]  T. McIntyre,et al.  Cytotoxic Phospholipid Oxidation Products , 2007, Journal of Biological Chemistry.

[13]  A. Zalewski,et al.  Lp-PLA2: a new kid on the block. , 2006, Clinical chemistry.

[14]  S. Kondo,et al.  Mutational analysis of the Lem3p-Dnf1p putative phospholipid-translocating P-type ATPase reveals novel regulatory roles for Lem3p and a carboxyl-terminal region of Dnf1p independent of the phospholipid-translocating activity of Dnf1p in yeast. , 2006, Biochemical and biophysical research communications.

[15]  A. Zalewski,et al.  Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target. , 2006, Current opinion in pharmacology.

[16]  A. Zalewski,et al.  Lp-PLA2: a new kid on the block. , 2006, Clinical chemistry.

[17]  S. Higuchi,et al.  Plasma phosphatidylcholine hydroperoxide as a new marker of oxidative stress in alcoholic patients Published, JLR Papers in Press, February 1, 2004. DOI 10.1194/jlr.M400008-JLR200 , 2004, Journal of Lipid Research.

[18]  A. Ohta,et al.  A Novel Membrane Protein, Ros3p, Is Required for Phospholipid Translocation across the Plasma Membrane in Saccharomyces cerevisiae * , 2002, The Journal of Biological Chemistry.

[19]  H. Arai,et al.  Platelet-activating factor acetylhydrolase (PAF-AH). , 2002, Journal of biochemistry.

[20]  J. C. Hinshaw,et al.  Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists* , 2001, The Journal of Biological Chemistry.

[21]  G. Zimmerman,et al.  Platelet-activating factor and related lipid mediators. , 2000, Annual review of biochemistry.

[22]  R. Murphy,et al.  Inflammatory Platelet-activating Factor-like Phospholipids in Oxidized Low Density Lipoproteins Are Fragmented Alkyl Phosphatidylcholines* , 1999, The Journal of Biological Chemistry.

[23]  D. Tew,et al.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. , 1999, The Biochemical journal.

[24]  R. Murphy,et al.  Copper-Catalyzed Oxidation Mediates PAF Formation in Human LDL Subspecies: Protective Role of PAF:Acetylhydrolase in Dense LDL , 1997 .

[25]  R. Murphy,et al.  Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  F. Snyder,et al.  Biosynthesis of platelet-activating factor and enzyme inhibitors. , 1996, Advances in experimental medicine and biology.

[27]  E. Frankel.  Chemistry of free radical and singlet oxidation of lipids. , 1984, Progress in lipid research.

[28]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.